Taylor Jennifer K, Schoenbaum Michael, Katon Wayne J, Pincus Harold A, Hogan Diane M, Unutzer Jurgen
Green Ribbon Health, LLC, 5201 W Kennedy Blvd, Ste 205, Tampa, FL 33609, USA.
Am J Manag Care. 2008 Aug;14(8):497-504.
To determine optimal methods of identifying enrollees with possible depression for additional depression screening in the context of a care management program for chronically ill Medicare recipients.
Observational analysis of telephone and mail survey and claims data collected for the Medicare Health Support (MHS) program.
This study examines data from 14,902 participants with diabetes mellitus and/or congestive heart failure in the MHS program administered by Green Ribbon Health, LLC. Depression screening was performed by administering a 2-item screen (the Patient Health Questionnaire 2 [PHQ-2]) by telephone or by mail. Additional information about possible depression was drawn from International Classification of Diseases, Ninth Revision (ICD-9) depression diagnoses on claims and from self-reported use of antidepressant medications. We evaluated positive depression screens using the PHQ-2 administered via telephone versus mail, examined variations in screener-positive findings by care manager, and compared rates of positive screens with antidepressant use and with claims diagnoses of depression.
Almost 14% of participants received an ICD-9 diagnosis of depression during the year before program enrollment; 7.1% reported taking antidepressants, and 5.1% screened positive for depression on the PHQ-2. We found substantial variation in positive depression screens by care manager that could not be explained by case mix, prior depression diagnoses, or current depression treatment. After adjusting for demographic and clinical differences, the PHQ-2-positive screen rates were 6.5% by telephone and 14.1% by mail (P <.001).
A multipronged effort composed of mail screening (using the PHQ-2), self-reported antidepressant use, and claims diagnoses of depression may capture the greatest number of enrollees with possible depression.
在针对患有慢性病的医疗保险受益人的护理管理项目背景下,确定识别可能患有抑郁症的登记参与者以进行额外抑郁症筛查的最佳方法。
对为医疗保险健康支持(MHS)项目收集的电话和邮件调查数据以及理赔数据进行观察性分析。
本研究检查了由绿丝带健康有限责任公司管理的MHS项目中14902名患有糖尿病和/或充血性心力衰竭的参与者的数据。通过电话或邮件进行两项筛查(患者健康问卷2[PHQ - 2])来进行抑郁症筛查。关于可能患有抑郁症的其他信息来自理赔记录中的国际疾病分类第九版(ICD - 9)抑郁症诊断以及自我报告的抗抑郁药物使用情况。我们评估了通过电话与邮件方式使用PHQ - 2进行的抑郁症筛查阳性情况,检查了不同护理经理筛查结果为阳性的差异,并比较了筛查阳性率与抗抑郁药物使用情况以及抑郁症理赔诊断情况。
在项目登记前一年,近14%的参与者被ICD - 9诊断为患有抑郁症;7.1%的人报告服用抗抑郁药物,5.1%的人在PHQ - 2筛查中抑郁症呈阳性。我们发现不同护理经理的抑郁症筛查阳性情况存在显著差异,这种差异无法用病例组合、既往抑郁症诊断或当前抑郁症治疗情况来解释。在调整了人口统计学和临床差异后,通过电话进行PHQ - 2筛查的阳性率为6.5%,通过邮件筛查的阳性率为14.1%(P <.001)。
由邮件筛查(使用PHQ - 2)、自我报告的抗抑郁药物使用情况以及抑郁症理赔诊断组成的多管齐下的努力可能会发现最多数量的可能患有抑郁症的登记参与者。